Sunmax Biotechnology Co Ltd (4728) — Long-term Investment Intensity
Sunmax Biotechnology Co Ltd (4728) has a Long-term Investment Intensity of 3.3% as of September 2019. Long-term investments of NT$32.94 Million represent 3.3% of total assets of NT$998.67 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 4728 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sunmax Biotechnology Co Ltd Long-term Investment Intensity (2017–2018)
This chart shows how Sunmax Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 3.3%, reflecting long-term investments of NT$32.94 Million against total assets of NT$998.67 Million TWD. Explore how well can Sunmax Biotechnology Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sunmax Biotechnology Co Ltd (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Sunmax Biotechnology Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 4728 market cap overview.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.5% | NT$64.08 Million | NT$757.89 Million | ▼ -0.6 pp |
| 2017 | 9.1% | NT$60.12 Million | NT$660.92 Million | — |